This Article Full Text Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bredie, S.J.H. Articles by Stalenhoef, A.F.H. Search for Related Content PubMed PubMed Citation Articles by Bredie, S.J.H. Articles by Stalenhoef, A.F.H.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:834-840.)
© 1997 American Heart Association, Inc.

Articles

Segregation Analysis of Plasma Apolipoprotein B Levels in Familial Combined Hyperlipidemia

S.J.H. Bredie; J. van Drongelen; L.A. Kiemeney; P.N.M. Demacker; T.H. Beaty; ; A.F.H. Stalenhoef

From the Department of Medicine, Division of General Internal Medicine, University Hospital Nijmegen (S.J.H.B., P.N.M.D., A.F.H.S.), and the Department of Epidemiology, University of Nijmegen (J. van D., L.A.K.), The Netherlands; and the Department of Epidemiology, School of Hygiene and Public Health, Johns Hopkins University, Baltimore, Maryland (T.H.B.).

Correspondence to A.F.H. Stalenhoef, MD, PhD, Department of Medicine, Division of General Internal Medicine, University Hospital Nijmegen, PO Box 9101, 6500 HB Nijmegen, The Netherlands.

Abstract Familial combined hyperlipidemia (FCH) is a heritable lipid disorder that is associated with an increased risk of premature cardiovascular disease. An elevated plasma apolipoprotein (apo) B concentration is reported to be a diagnostic feature of the disorder. Recently we demonstrated a strong relation between plasma apoB concentrations and the cholesterol concentration in VLDL plus LDL, both elevated in FCH families. Therefore, examination of the inheritance of elevated plasma apoB levels in FCH families may reveal important information about the mechanism responsible for the aggregation of elevated plasma lipids in FCH. This study included 663 Dutch family members in 40 families ascertained through FCH probands. Plasma apoB concentration correlated significantly with apoB-related cholesterol both in the probands and the relatives (r=.83 and r=.90, respectively). Adjustment for age, sex, body mass index, and smoking habits accounted for 35.7% of the variation in apoB levels, and there was strong familial aggregation in adjusted apoB levels in these families. Complex segregation analysis was performed to determine the mechanism of inheritance behind this familial aggregation. The aggregation of elevated apoB levels was best explained by a major gene effect inherited by a codominant mechanism. Estimated mean apoB levels for the three supposed genotypes AA, AB, and BB were 111.5, 126.7, and 165.7 mg/dL, respectively, with relative frequencies of 43.5%, 44.9%, and 11.6%, respectively. In conclusion, despite assumed metabolic and genetic heterogeneity of FCH, there is clear evidence for a single gene effect on apoB concentrations in families ascertained through FCH. Linkage studies based on this analysis may further clarify the molecular basis of the apoB regulation in these families.

Key Words: lipoproteins • human genetics • apoB

This article has been cited by other articles:

				R. M. Cantor, T. de Bruin, N. Kono, S. Napier, A. van Nas, H. Allayee, and A. J. Lusis Quantitative Trait Loci for Apolipoprotein B, Cholesterol, and Triglycerides in Familial Combined Hyperlipidemia Pedigrees Arterioscler Thromb Vasc Biol, October 1, 2004; 24(10): 1935 - 1941. [Abstract] [Full Text] [PDF]

				M. J. Veerkamp, J. de Graaf, J. C.M. Hendriks, P. N.M. Demacker, and A. F.H. Stalenhoef Nomogram to Diagnose Familial Combined Hyperlipidemia on the Basis of Results of a 5-Year Follow-Up Study Circulation, June 22, 2004; 109(24): 2980 - 2985. [Abstract] [Full Text] [PDF]

				R. P. Naoumova, S. A. Bonney, S. Eichenbaum-Voline, H. N. Patel, B. Jones, E. L. Jones, J. Amey, S. Colilla, C. K.Y. Neuwirth, R. Allotey, et al. Confirmed Locus on Chromosome 11p and Candidate Loci on 6q and 8p for the Triglyceride and Cholesterol Traits of Combined Hyperlipidemia Arterioscler Thromb Vasc Biol, November 1, 2003; 23(11): 2070 - 2077. [Abstract] [Full Text] [PDF]

				H. Allayee, K. L. Krass, P. Pajukanta, R. M. Cantor, C. J.H. van der Kallen, R. Mar, J. I. Rotter, T. W.A. de Bruin, L. Peltonen, and A. J. Lusis Locus for Elevated Apolipoprotein B Levels on Chromosome 1p31 in Families With Familial Combined Hyperlipidemia Circ. Res., May 3, 2002; 90(8): 926 - 931. [Abstract] [Full Text] [PDF]

				M. J. Veerkamp, J. de Graaf, S. J.H. Bredie, J. C.M. Hendriks, P. N.M. Demacker, and A. F.H. Stalenhoef Diagnosis of Familial Combined Hyperlipidemia Based on Lipid Phenotype Expression in 32 Families: Results of a 5-Year Follow-Up Study Arterioscler Thromb Vasc Biol, February 1, 2002; 22(2): 274 - 282. [Abstract] [Full Text] [PDF]

				J. Pihlajamaki, M. Austin, K. Edwards, and M. Laakso A Major Gene Effect on Fasting Insulin and Insulin Sensitivity in Familial Combined Hyperlipidemia Diabetes, October 1, 2001; 50(10): 2396 - 2401. [Abstract] [Full Text]

				J. M.W. Geurts, R. G.J.H. Janssen, M. M.J. van Greevenbroek, C. J.H. van der Kallen, R. M. Cantor, X.-d. Bu, B. E. Aouizerat, H. Allayee, J. I. Rotter, and T. W.A. de Bruin Identification of TNFRSF1B as a novel modifier gene in familial combined hyperlipidemia Hum. Mol. Genet., September 1, 2000; 9(14): 2067 - 2074. [Abstract] [Full Text] [PDF]

				P. An, T. Rice, J. Gagnon, I. B. Borecki, J. Bergeron, J.-P. Despres, A. S. Leon, J. S. Skinner, J. H. Wilmore, C. Bouchard, et al. Segregation Analysis of Apolipoproteins A-1 and B-100 Measured Before and After an Exercise Training Program : The HERITAGE Family Study Arterioscler Thromb Vasc Biol, March 1, 2000; 20(3): 807 - 814. [Abstract] [Full Text] [PDF]

				J. Pihlajamaki, L. Karjalainen, P. Karhapaa, I. Vauhkonen, and M. Laakso Impaired Free Fatty Acid Suppression During Hyperinsulinemia Is a Characteristic Finding in Familial Combined Hyperlipidemia, but Insulin Resistance Is Observed Only in Hypertriglyceridemic Patients Arterioscler Thromb Vasc Biol, January 1, 2000; 20(1): 164 - 170. [Abstract] [Full Text] [PDF]

				E. Voyiaziakis, C. Ko, S. M. O'Rourke, and L.-S. Huang Genetic control of hepatic apoB-100 secretion in human apoB transgenic mouse strains J. Lipid Res., November 1, 1999; 40(11): 2004 - 2012. [Abstract] [Full Text]

				H. Allayee, K. L. Krass, P. Pajukanta, R. M. Cantor, C. J.H. van der Kallen, R. Mar, J. I. Rotter, T. W.A. de Bruin, L. Peltonen, and A. J. Lusis Locus for Elevated Apolipoprotein B Levels on Chromosome 1p31 in Families With Familial Combined Hyperlipidemia Circ. Res., May 3, 2002; 90(8): 926 - 931. [Abstract] [Full Text] [PDF]